Clover outlines FY 2026 revenue of $2.92B-$3.0B as 4.5-Star rating boosts 2027 flexibility — See source for full details.
$CLOV
Price history, market instrument context, member research, and related headlines in one place.
CLOV key statistics
NasdaqGSUSD
52-week range
$1.5877%$5.59
Latest session $4.61–$4.76Clover Health Investments, Corp. (CLOV) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $4.68, down $0.11 (2.30%) from the previous close of $4.79. It has traded between $4.61 and $4.76 in the latest session. Over the past year it has ranged from $1.58 to $5.59, leaving it in the upper quarter of its 52-week range (77%). Reported volume for the session was 3.4M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $CLOV research…